These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7911690)

  • 1. Three types of liver cell dysplasia (LCD) in small cirrhotic nodules are distinguishable by karyometry and PCNA labelling, and their features resemble distinct grades of hepatocellular carcinoma.
    Zhao M; Zhang NX; Du ZY; Laissue JA; Zimmermann A
    Histol Histopathol; 1994 Jan; 9(1):73-83. PubMed ID: 7911690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenascin and type IV collagen expression in liver cell dysplasia and in hepatocellular carcinoma.
    Zhao M; Laissue JA; Zimmermann A
    Histol Histopathol; 1996 Apr; 11(2):323-33. PubMed ID: 8861754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of ras oncogene p21 product and proliferating cell nuclear antigen in liver cirrhosis and the correlation with liver cell dysplasia].
    Feng Z; He R; Lu Z; Ling Y
    Zhonghua Gan Zang Bing Za Zhi; 2000 Dec; 8(6):343-5. PubMed ID: 11135691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver cell dysplasia and hepatocellular carcinoma in non-A, non-B hepatitis.
    Lefkowitch JH; Apfelbaum TF
    Arch Pathol Lab Med; 1987 Feb; 111(2):170-3. PubMed ID: 3028314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological features of cirrhosis with hepatitis C virus for prediction of hepatocellular carcinoma development; a prospective study.
    Makino Y; Shiraki K; Sugimoto K; Ito T; Yamanaka T; Fujikawa K; Takase K; Nakano T
    Anticancer Res; 2000; 20(5C):3709-15. PubMed ID: 11268443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macroregenerative nodules in a series of adult cirrhotic liver explants: issues of classification and nomenclature.
    Hytiroglou P; Theise ND; Schwartz M; Mor E; Miller C; Thung SN
    Hepatology; 1995 Mar; 21(3):703-8. PubMed ID: 7875667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis.
    Lee RG; Tsamandas AC; Demetris AJ
    Hepatology; 1997 Dec; 26(6):1415-22. PubMed ID: 9397980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative image cytometric DNA ploidy of liver cell dysplasia and hepatocellular carcinoma.
    Rubin EM; DeRose PB; Cohen C
    Mod Pathol; 1994 Aug; 7(6):677-80. PubMed ID: 7991527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    Szczepański W
    Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large cell dysplasia of hepatocytes, is it a premalignant condition?
    Kovács L; Elek G
    Acta Morphol Hung; 1987; 35(1-2):47-57. PubMed ID: 3124508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preneoplastic lesions in chronic hepatitis C.
    Thung SN; Hytiroglou P; Fiel I; Theise N
    Princess Takamatsu Symp; 1995; 25():171-8. PubMed ID: 8875622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferating cell nuclear antigen (PCNA) activity in hepatocellular carcinoma, benign peri-neoplastic and normal liver.
    Mun KS; Cheah PL; Baharudin NB; Looi LM
    Malays J Pathol; 2006 Dec; 28(2):73-7. PubMed ID: 18376794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of micronuclei formation and nuclear anomalies in regenerative nodules of human cirrhotic livers and relationship to hepatocellular carcinoma.
    de Almeida TM; Leitão RC; Andrade JD; Beçak W; Carrilho FJ; Sonohara S
    Cancer Genet Cytogenet; 2004 Apr; 150(1):16-21. PubMed ID: 15041218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological significance of adenomatous hyperplasia of the liver].
    Nakashima O; Kojiro M
    Nihon Rinsho; 1994 Jan; 52(1):75-9. PubMed ID: 8114314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity.
    Donato MF; Arosio E; Del Ninno E; Ronchi G; Lampertico P; Morabito A; Balestrieri MR; Colombo M
    Hepatology; 2001 Sep; 34(3):523-8. PubMed ID: 11526538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with chronic hepatitis B.
    Koo JS; Kim H; Park BK; Ahn SH; Han KH; Chon CY; Park C; Park YN
    J Clin Gastroenterol; 2008 Jul; 42(6):738-43. PubMed ID: 18277883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent occurrence of hepatocellular carcinoma in cirrhotic livers after surgical resection of atypical adenomatous hyperplasia (borderline hepatocellular lesion): a follow-up study.
    Kaji K; Terada T; Nakanuma Y
    Am J Gastroenterol; 1994 Jun; 89(6):903-8. PubMed ID: 8198103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Karyometric analysis of liver cell dysplasia and hepatocellular carcinoma. Evidence against precancerous nature of liver cell dysplasia.
    Henmi A; Uchida T; Shikata T
    Cancer; 1985 Jun; 55(11):2594-9. PubMed ID: 2986818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical p53 in hepatocellular carcinoma and liver cell dysplasia.
    Cohen C; DeRose PB
    Mod Pathol; 1994 Jun; 7(5):536-9. PubMed ID: 7937718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.